ContractSublicensing Agreement • April 2nd, 2018Contract TypeSublicensing AgreementFiledApril 2nd, 2018Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors
Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors